Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis.

Gastroenterology - 1 Mar 1995

Olerup O, Olsson R, Hultcrantz R, Broome U

Abstract excerpt

BACKGROUND/AIMS: The association between primary sclerosing cholangitis (PSC) and the HLA haplotype A1, B8, DR3, DQ2 is well established. During the last few years, several additional HLA associations have been suggested in PSC. Furthermore, two different HLA-DR specificities have been reported t...

Topics

Alleles
Biomarkers
Cholangitis, Sclerosing
Codon
Genes
HLA-DQ Antigens
HLA-DQ alpha-Chains
HLA-DR Antigens
Haplotypes
Humans
Phenotype
Survival Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 7875491
DOI: 10.1016/0016-5085(95)90463-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-7875491-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis.PMID 7875491Read ↗

HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.Semantic proximity Read ↗

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.Semantic proximity Read ↗

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.Semantic proximity Read ↗

Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis.Semantic proximity Read ↗

Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.Semantic proximity Read ↗

Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.Semantic proximity Read ↗

HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.Semantic proximity Read ↗

Genetic epidemiology of primary sclerosing cholangitisSemantic proximity Read ↗

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.Semantic proximity Read ↗

Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis.Semantic proximity Read ↗

Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.Semantic proximity Read ↗

HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.